You are currently viewing a new version of our website. To view the old version click .
Pharmaceutics
  • Correction
  • Open Access

12 December 2025

Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710

,
,
,
,
,
,
,
,
and
1
CNR-Institute for Complex Systems (ISC), and Physics Department, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
2
Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00146 Rome, Italy
3
CNR-Institute for Biological Systems, Secondary Office of Rome—Sapienza University of Rome, 00185 Rome, Italy
4
Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy

Addition of an Author

Eugenia Belcastro was not included as an author in the original publication [1]. The corrected authorship and Author Contributions statement appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
  • Simona Sennato 1,†, Giorgia Paldino 2,†, Cecilia Bombelli 3, Irene Mezzani 2, Stefania Petrini 2, Eugenia Belcastro 2, Domenico Vittorio Delfino 4, Francesco Fiorentino 5, Carlotta Marianecci 5, Alessia Ciogli 5, Dante Rotili 6, Francesca Ceccacci 3,* and Alessandra Fierabracci 2,*
2 
Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00146 Rome, Italy; giorgiapld@gmail.com (G.P.); irene.mezzani@opbg.net (I.M.); stefania.petrini@opbg.net (S.P.); eugenia.belcastro@unipi.it (E.B.)
  • Author Contributions: Conceptualization, F.C., S.S., C.B., D.V.D., D.R. and A.F.; methodology, G.P., F.C., S.P., I.M., S.S., C.B., F.F., E.B. and A.F.; investigation, G.P., F.C., I.M., S.S., C.B., F.F., C.M., A.C., D.R. and A.F.; data curation, F.C., S.P., S.S., C.B., C.M. and A.C.; writing—original draft preparation, F.C., S.S., C.B. and A.F.; writing—review and editing, A.F. and F.C.; supervision, A.F.; project administration, A.F.; funding acquisition, A.F. All authors have read and agreed to the published version of the manuscript.

Reference

  1. Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.